PTSD

When someone is suffering from post-traumatic stress disorder, psychiatrists will sometimes have them place themselves in stress-triggering environments. An experimental wearable system has now been shown to make such treatment much more effective.

Studies continue to illuminate the wide-ranging benefits of physical activity when it comes to brain health, and new research has shown how that might include treatment of post-traumatic stress disorder (PTSD).

Striking new research proposes taking a common anti-inflammatory drug soon after experiencing a traumatic event could help people forget upsetting memories and reduce their risk of developing post-traumatic stress disorder (PTSD).

A trial exploring MDMA-assisted therapy in a group setting is about to commence following the resolution of a clinical hold placed by the FDA that paused progress for several months. The trial's goal is to make MDMA-assisted therapy more cost-effective.

The first results from Phase 3 trials testing MDMA-assisted psychotherapy for PTSD have been announced. The promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy paving the way for a landmark FDA approval in 2023.

Surfing the wave of new research into medical uses for psychedelic compounds, the Icahn School of Medicine at Mount Sinai has launched a dedicated psychedelic center focusing on the study of MDMA and psilocybin for PTSD and other stress-related conditions.

For the first time in decades, a pilot study has explored the effects of MDMA therapy in couples within the framework of a robust clinical trial. Following on from ongoing research into MDMA-assisted therapy for PTSD, the results are promising.

The FDA has approved a platform called NightWare, designed to help improve sleep in post-traumatic stress disorder patients suffering from recurrent nightmares. The system is an Apple Watch app that will only be available by prescription.

Researchers have conducted the world’s first meta-analysis of the relationship between PTSD and dementia. Encompassing over a million subjects the study found PTSD can double a person’s risk of developing dementia in their senior years.

A new pilot study has demonstrated nitrous oxide, commonly known as laughing gas, may help military veterans suffering from PTSD. A larger trial is now underway after several studies demonstrated potential new uses for the gas.

A new study is looking at the long-term efficacy of MDMA-assisted psychotherapy for the treatment of PTSD, finding the substantial beneficial effects of the therapy hold strong for over a year and patients continue to improve after the MDMA sessions.

In research that could have implications for sufferers of post-traumatic stress disorder, scientists have found it is possible to effectively erase memories of a traumatic event in fruit flies by keeping them in the dark for two days.